| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Less net increase in cash and cash equivalents classified within current assets held for sale | - | 15,058 |
| Cash Cash Equivalent Restricted Cash And Restricted Cash Equivalent Period Increase Decrease Including Exchange Rate Effect Continuing Operations Excluding Assets Held For Sale | - | -16,398 |
| Net decrease in cash, and cash equivalents, and restricted cash | -5,426 | -1,340 |
BIOCRYST PHARMACEUTICALS INC (BCRX)
BIOCRYST PHARMACEUTICALS INC (BCRX)